Literature DB >> 19563613

High dietary methionine plus cholesterol stimulates early atherosclerosis and late fibrous cap development which is associated with a decrease in GRP78 positive plaque cells.

Anthony Zulli1, David L Hare.   

Abstract

The role of homocysteine, or its precursor methionine, in the formation of fibrous caps and its association with endoplasmic reticulum (ER) stress is unclear. Homocysteine can stimulate collagen accumulation and upregulate the ER stress chaperone glucose regulated protein 78 (GRP78). The aim of this study was to determine if high dietary methionine would increase fibrous caps, and that removal of an atherogenic diet would decrease the amount of ER stressed cells. New Zealand white rabbits were fed for 2, 4, or 12 weeks an atherogenic diet [1% methionine + 0.5% cholesterol (2MC, 4MC or 12MC)]; for 4 or 12 weeks a 0.5% cholesterol diet (4Ch, 12Ch); and to study plaque regression, an MC diet for 2 or 4 weeks accompanied by 10 weeks of a normal diet (2MCr, 4MCr). Endothelial function, atherosclerosis and GRP78 positive cells were studied. Endothelial function was abolished in 4MC and atherosclerosis increased 17-fold (P < 0.05) compared with 4Ch. Fibrous caps composed 48% of total plaque area in 12MC vs. 10% in 12Ch (P < 0.01), and 12MC expressed less GRP78 plaque cells vs. 12Ch (P < 0.01). Four MCr had less plaque GRP78 cells than 12MC (P < 0.05) and less endothelial GRP78 cells (P < 0.01). In addition, GRP78 positive cells were the highest in 4MC, but decreased in all other groups (P < 0.01). GRP78 positive cells within the fibrous cap inversely correlated with cap size (r(2) = 0.9). These studies suggest that high dietary methionine could be beneficial for plaque stabilisation, and a normal diet also stabilises plaque and decreases the number of stressed plaque cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563613      PMCID: PMC2697553          DOI: 10.1111/j.1365-2613.2009.00649.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  54 in total

1.  The ER function BiP is a master regulator of ER function.

Authors:  Linda M Hendershot
Journal:  Mt Sinai J Med       Date:  2004-10

2.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

3.  Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

Authors:  Masaru Iwai; Rui Chen; Zhen Li; Tetsuya Shiuchi; Jun Suzuki; Ayumi Ide; Masahiro Tsuda; Midori Okumura; Li-Juan Min; Masaki Mogi; Masatsugu Horiuchi
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

Review 4.  Homocysteine and cardiovascular disease: cause or effect?

Authors:  L Brattström; D E Wilcken
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

5.  Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells.

Authors:  A Majors; L A Ehrhart; E H Pezacka
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

Review 6.  Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD.

Authors:  Bruno Vergès
Journal:  Curr Opin Lipidol       Date:  2006-12       Impact factor: 4.776

7.  An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit.

Authors:  P A Fennessy; J H Campbell; G R Campbell
Journal:  Clin Sci (Lond)       Date:  1994-12       Impact factor: 6.124

8.  Embryonic stem cells markers are present within rabbit atherosclerotic plaques.

Authors:  Anthony Zulli; Brian F Buxton; M Jane Black; David L Hare
Journal:  Histol Histopathol       Date:  2008-06       Impact factor: 2.303

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

Review 10.  The mammalian unfolded protein response.

Authors:  Martin Schröder; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

View more
  6 in total

Review 1.  Cysteine/cystine redox signaling in cardiovascular disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2010-12-03       Impact factor: 7.376

2.  A physiologically relevant atherogenic diet causes severe endothelial dysfunction within 4 weeks in rabbit.

Authors:  Sudarshan Rai; David L Hare; Anthony Zulli
Journal:  Int J Exp Pathol       Date:  2009-09-15       Impact factor: 1.925

3.  Effect of aqueous extract of Vernonia amygdalina on atherosclerosis in rabbits.

Authors:  Omotola Abdulmalik; Olulola Olutoyin Oladapo; Modupeola Oluwabunmi Bolaji
Journal:  ARYA Atheroscler       Date:  2016-01

4.  Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.

Authors:  Khira Othmani Mecif; Souhila Aouichat Bouguerra; Yasmina Benazzoug
Journal:  J Nutr Metab       Date:  2017-01-04

5.  Undercarboxylated osteocalcin is associated with vascular function in female older adults but does not influence vascular function in male rabbit carotid artery ex vivo.

Authors:  Alexander Tacey; Cassandra Smith; Mary N Woessner; Paul Chubb; Christopher Neil; Gustavo Duque; Alan Hayes; Anthony Zulli; Itamar Levinger
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

6.  The Effect of an Atherogenic Diet and Acute Hyperglycaemia on Endothelial Function in Rabbits Is Artery Specific.

Authors:  Alexander Tacey; Tawar Qaradakhi; Cassandra Smith; Chris Pittappillil; Alan Hayes; Anthony Zulli; Itamar Levinger
Journal:  Nutrients       Date:  2020-07-16       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.